PAR paradigm biopharmaceuticals limited..

Where are we on a deal?, page-1528

  1. 285 Posts.
    lightbulb Created with Sketch. 100
    For the record, I don't share Beaza's opinions about PR (I've never even met PR in real life), but asx11's comment that "an argument could be made that PR is underpaid" felt like a bridge too far...

    I haven't given up on PR, a lot of what PR has said in the past can be written off as over-optimism, and I still think that this time he will come through for us.

    However, if PR hits us with another discounted Bell Potter capital raise after all he has said over the last two months (e.g. "very good solution for the company", "on track", "very confident of funding through to interim analysis", etcetera), then my opinion about him will change.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
32.0¢
Change
-0.015(4.48%)
Mkt cap ! $124.6M
Open High Low Value Volume
33.5¢ 34.0¢ 31.5¢ $215.7K 663.5K

Buyers (Bids)

No. Vol. Price($)
3 30081 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 10905 1
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.